Pieris Pharmaceuticals (PIRS) Stock Chart & Stock Price History → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free PIRS Stock Alerts $11.16 +0.02 (+0.18%) (As of 05/9/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Pieris Pharmaceuticals Stock Price Performance5 Day Performance+0.72%1 Month Performance-21.19%3 Month Performance-15.45%6 Month Performance-42.28%Year-To-Date Performance-23.35%1 Year Performance-83.78% Receive PIRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details PIRS Stock Chart for Friday, May, 10, 2024 PIRS Chart by TradingView Pieris Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2024$11.14$11.16+0.18%$11.32$11.162,142 shs$13.81 million05/08/2024$11.04$11.14+0.91%$11.25$10.908,821 shs$13.81 million05/07/2024$11.06$11.04-0.18%$11.18$10.8710,608 shs$13.69 million05/06/2024$11.08$11.06-0.18%$11.41$10.8017,029 shs$13.71 million05/03/2024$11.24$11.08-1.42%$11.20$10.6031,361 shs$13.74 million05/02/2024$11.68$11.24-3.77%$11.59$10.8281,346 shs$13.94 million Get the Latest News and Ratings for PIRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/01/2024$11.71$11.68-0.26%$11.94$11.5047,621 shs$14.48 million04/30/2024$11.71$11.71$11.90$11.6213,857 shs$14.52 million04/29/2024$11.72$11.71-0.09%$12.14$11.5314,974 shs$14.49 million04/26/2024$11.60$11.72+1.03%$11.93$11.5016,949 shs$14.53 million04/25/2024$11.93$11.60-2.77%$11.74$11.3828,382 shs$14.38 million04/24/2024$12.04$11.93-0.91%$11.93$11.1739,965 shs$1.18 billion04/23/2024$11.69$12.04+3.01%$12.93$11.16115,526 shs$1.19 billion04/22/2024$11.60$11.69+0.76%$12.08$11.2822,707 shs$14.45 million04/19/2024$12.40$11.60-6.45%$12.45$11.0423,998 shs$14.35 million04/18/2024$12.57$12.40-1.34%$13.35$12.258,120 shs$15.33 million04/17/2024$13.12$12.57-4.21%$13.83$12.407,780 shs$15.54 million04/16/2024$13.60$13.12-3.53%$13.84$12.804,004 shs$16.23 million04/15/2024$13.74$13.60-1.01%$13.92$13.047,020 shs$16.82 million04/12/2024$14.19$13.71-3.38%$14.39$13.622,909 shs$16.96 million04/11/2024$14.16$14.19+0.23%$14.85$14.003,068 shs$17.55 million04/10/2024$14.50$14.16-2.37%$14.79$14.003,492 shs$17.51 million04/09/2024$13.86$14.50+4.68%$15.20$13.854,013 shs$17.94 million04/08/2024$13.74$13.86+0.81%$14.40$13.643,296 shs$17.14 million04/05/2024$13.72$13.74+0.12%$14.15$13.644,194 shs$16.99 million04/04/2024$13.78$13.72-0.46%$14.72$13.605,138 shs$16.97 million04/03/2024$14.24$13.78-3.20%$14.26$13.755,076 shs$17.05 million04/02/2024$14.96$14.24-4.81%$14.83$14.026,306 shs$17.60 million04/01/2024$14.66$14.96+2.07%$15.20$14.408,734 shs$18.49 million03/29/2024$14.66$14.66$15.40$14.655,861 shs$18.11 million03/28/2024$15.50$14.66-5.42%$15.40$14.664,983 shs$18.11 million03/27/2024$15.04$15.50+3.03%$15.64$14.5415,420 shs$19.15 million03/26/2024$14.54$15.04+3.47%$15.20$14.604,484 shs$18.58 million03/25/2024$16.00$14.54-9.15%$16.00$14.3236,975 shs$17.96 million03/22/2024$15.99$16.00+0.05%$17.60$15.699,175 shs$19.77 million03/21/2024$16.80$15.99-4.81%$16.79$15.208,132 shs$19.76 million03/20/2024$17.24$16.80-2.55%$19.21$16.579,435 shs$20.76 million03/19/2024$16.80$17.24+2.62%$19.60$16.1030,919 shs$21.30 million03/18/2024$13.52$16.80+24.26%$22.32$14.02118,629 shs$20.76 million03/15/2024$13.68$13.52-1.17%$14.03$13.154,264 shs$16.71 millionForget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details03/14/2024$13.94$13.68-1.89%$14.36$13.604,248 shs$16.90 million03/13/2024$14.24$13.94-2.08%$14.74$13.203,589 shs$17.23 million03/12/2024$13.60$14.24+4.71%$14.40$12.407,681 shs$17.60 million03/11/2024$14.40$13.60-5.56%$14.88$13.362,830 shs$16.81 million03/08/2024$14.23$14.40+1.18%$14.92$13.547,155 shs$17.79 million03/07/2024$13.53$14.23+5.20%$14.40$13.444,109 shs$17.59 million03/06/2024$13.76$13.53-1.69%$14.40$13.445,995 shs$16.72 million03/05/2024$13.59$13.76+1.24%$14.79$13.6714,106 shs$17.00 million03/04/2024$13.84$13.59-1.79%$13.84$13.223,625 shs$16.80 million03/01/2024$13.21$13.84+4.78%$13.84$13.143,073 shs$17.10 million02/29/2024$13.61$13.21-2.94%$13.59$13.201,744 shs$16.32 million02/28/2024$12.85$13.61+5.92%$13.76$12.838,705 shs$16.81 million02/27/2024$13.28$12.85-3.25%$13.60$12.573,130 shs$15.88 million02/26/2024$13.01$13.28+2.09%$13.36$12.622,858 shs$16.41 million02/23/2024$12.90$13.01+0.81%$13.44$12.403,146 shs$16.07 million02/22/2024$13.61$12.90-5.17%$13.59$12.333,624 shs$15.95 million02/21/2024$13.53$13.61+0.59%$13.76$12.713,406 shs$16.81 million02/20/2024$12.50$13.53+8.26%$13.60$12.633,132 shs$16.72 million02/19/2024$12.50$12.50$13.42$12.174,384 shs$15.44 million02/16/2024$12.70$12.50-1.58%$13.42$12.174,369 shs$15.44 million02/15/2024$12.40$12.70+2.39%$12.80$12.003,391 shs$15.69 million02/14/2024$12.43$12.40-0.26%$13.00$11.885,489 shs$15.32 million02/13/2024$12.96$12.43-4.07%$13.20$12.247,538 shs$15.36 million02/12/2024$13.20$12.96-1.82%$13.70$12.883,253 shs$16.01 million02/09/2024$12.85$13.20+2.74%$13.42$12.834,089 shs$16.31 million Related Companies: Edesa Biotech Stock Price Chart NanoViricides Stock Price Chart Tonix Pharmaceuticals Stock Price Chart Traws Pharma Stock Price Chart Vaxxinity Stock Price Chart Kiora Pharmaceuticals Stock Price Chart Aytu BioPharma Stock Price Chart ABVC BioPharma Stock Price Chart Purple Biotech Stock Price Chart FSD Pharma Stock Price Chart Receive PIRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PIRS) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pieris Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.